Beta-blockers are drugs that improve the heart's ability to relax. WebMD looks at how this medication is used to treat heart failure. Skip to main content ... (ARNI), or angiotensin receptor ...

Does digitoxin still have a place in heart failure treatment? Two new studies reevaluate the role of cardiology’s oldest drug.

Market Overview of Heart Failure Drugs (2025–2035)The Heart Failure Drugs Market is poised for a transformative decade between 2025 and 2035. As heart failure continues to pose a major global health ...

The global Heart Failure Drugs Market is valued at $8.6 billion in 2024 and is projected to reach a value of $21.4 billion by 2035.This growth represents a Compound Annual Growth Rate (CAGR) of 12.1% ...

The SARAH clinical trial examined the effects of the heart-failure medication sacubitril-valsartan, an angiotensin receptor neprilysin inhibitor or ARNI, on preventing further heart damage among ...

Heart failure with preserved ejection function is a lethal form of heart failure, with few effective treatments. ... Currently, there are only two drugs for HFpEF: SGLT2 inhibitor and ARNI.

GPs can start treatment with certain heart failure drugs that previously had to be initiated by a specialist, NICE has said in updated guidance. Sodium-glucose cotransporter-2 (SGLT2) inhibitors and ...

More information: Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection ...